Grant: Collaborative Health Research Projects

HepatoCellular Carcinoma (HCC) (liver cancer) is the fifth most common cancer in the world and third cause of cancermortality and its incidence is increasing worldwide and intra-arterial therapies are now the preferred therapeutic approach foradvanced HCC. Unlike other existing interventional methods, we propose a non-invasive treatment concept which consistsin injecting special drug-carrying biodegradable magnetic carriers being navigated directly to the site being treated using aclinical Magnetic Resonance Imaging (MRI) scanner in order to enhance the treatment of liver cancer. We have previouslyproven its feasibility in a rabbit model. However, the technology must first be adapted to the human scale before consideringclinical translation, which is the main goal of this project.